Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Pharmacological Research|July 31, 2025
Beyond the surface: P2Y receptor downstream pathways, TLR crosstalk and therapeutic implications for infection and autoimmunityLena Rueschpler, Sebastian Schloer
Redox Biology|April 25, 2026
Reactive oxygen species and metabolic checkpoints shape plasmacytoid dendritic cell fate in infection and autoimmunityLena Rueschpler, Sebastian Schloer
Pharmacological Research|December 3, 2025
Endolysosomes as a sorting hub for emerging viruses: Gatekeepers of cellular defense, viral fate and promising therapeutic targetSophie Post, Lena Rueschpler, Sebastian Schloer
International Journal of Molecular Sciences|June 20, 2018
Annexins in Translational Research: Hidden Treasures to Be FoundSebastian Schloer, Denise Pajonczyk, Ursula Rescher
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Repurposing Antifungals for Host-Directed Antiviral Therapy?Sebastian Schloer, Jonas Goretzko, Ursula Rescher
Viruses|July 3, 2020
Combinatory Treatment with Oseltamivir and Itraconazole Targeting Both Virus and Host Factors in Influenza A Virus InfectionSebastian Schloer, Jonas Goretzko, Stephan Pleschka, et al.
Emerging Microbes & Infections|December 17, 2021
Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection <i>in vitro</i>Susann Kummer, Angelika Lander, Jonas Goretzko, et al.
Emerging Microbes & Infections|March 15, 2019
The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivoSebastian Schloer, Jonas Goretzko, Alexander Kühnl, et al.
Pharmaceutics|September 23, 2022
The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 DrugsAndré Schreiber, Benjamin Ambrosy, Oliver Planz, et al.
British Journal of Pharmacology|April 7, 2021
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitroSebastian Schloer, Linda Brunotte, Angeles Mecate-Zambrano, et al.
Pageof 3